LYS_BPCP9
ID LYS_BPCP9 Reviewed; 339 AA.
AC P19386;
DT 01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1990, sequence version 1.
DT 29-SEP-2021, entry version 104.
DE RecName: Full=Lysozyme;
DE EC=3.2.1.17;
DE AltName: Full=CP-9 lysin;
DE AltName: Full=Endolysin;
DE AltName: Full=Muramidase;
GN Name=CPL9;
OS Streptococcus phage Cp-9 (Bacteriophage Cp-9).
OC Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Caudoviricetes;
OC Caudovirales; Salasmaviridae; Cepunavirus.
OX NCBI_TaxID=10749;
OH NCBI_TaxID=1313; Streptococcus pneumoniae.
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX PubMed=2311937; DOI=10.1016/0378-1119(90)90116-9;
RA Garcia P., Garcia J.L., Garcia E., Sanchez-Puelles J.M., Lopez R.;
RT "Modular organization of the lytic enzymes of Streptococcus pneumoniae and
RT its bacteriophages.";
RL Gene 86:81-88(1990).
CC -!- FUNCTION: Responsible for the separation of the host daughter cells at
CC the end of cell division and participates in the liberation of progeny
CC bacteriophage into the medium. Strictly depends on the presence of
CC choline-containing cell walls for activity.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic
CC acid and N-acetyl-D-glucosamine residues in a peptidoglycan and
CC between N-acetyl-D-glucosamine residues in chitodextrins.;
CC EC=3.2.1.17;
CC -!- DOMAIN: The C-terminal domain comprising the repeats is involved in
CC choline binding. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 25 family.
CC {ECO:0000255|PROSITE-ProRule:PRU01252, ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M34780; AAA72845.1; -; Genomic_DNA.
DR PIR; JQ0438; MUBPC9.
DR SMR; P19386; -.
DR CAZy; GH25; Glycoside Hydrolase Family 25.
DR GO; GO:0003796; F:lysozyme activity; IEA:UniProtKB-EC.
DR GO; GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro.
DR GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR GO; GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro.
DR InterPro; IPR018337; Cell_wall/Cho-bd_repeat.
DR InterPro; IPR002053; Glyco_hydro_25.
DR InterPro; IPR008270; Glyco_hydro_25_AS.
DR InterPro; IPR018077; Glyco_hydro_fam25_subgr.
DR InterPro; IPR017853; Glycoside_hydrolase_SF.
DR Pfam; PF01473; Choline_bind_1; 2.
DR Pfam; PF19127; Choline_bind_3; 1.
DR Pfam; PF01183; Glyco_hydro_25; 1.
DR SMART; SM00641; Glyco_25; 1.
DR SUPFAM; SSF51445; SSF51445; 1.
DR PROSITE; PS51170; CW; 5.
DR PROSITE; PS00953; GLYCOSYL_HYDROL_F25_1; 1.
DR PROSITE; PS51904; GLYCOSYL_HYDROL_F25_2; 1.
PE 3: Inferred from homology;
KW Antimicrobial; Bacteriolytic enzyme; Glycosidase; Hydrolase; Repeat.
FT CHAIN 1..339
FT /note="Lysozyme"
FT /id="PRO_0000208261"
FT DOMAIN 5..201
FT /note="Ch-type lysozyme"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01252"
FT REPEAT 200..219
FT /note="Cell wall-binding 1"
FT REPEAT 220..239
FT /note="Cell wall-binding 2"
FT REPEAT 241..260
FT /note="Cell wall-binding 3"
FT REPEAT 261..280
FT /note="Cell wall-binding 4"
FT REPEAT 281..300
FT /note="Cell wall-binding 5"
FT REPEAT 303..322
FT /note="Cell wall-binding 6"
FT ACT_SITE 10
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01252"
FT ACT_SITE 92
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01252"
FT ACT_SITE 94
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01252"
SQ SEQUENCE 339 AA; 39151 MW; A2143F05BDED4EDD CRC64;
MVKKNDLFID VSSHNGYDIT GILEQMGTTN TIVKISESTT YLNPCLSAQV EQSTPIGFYH
FARFGGDVAE AEREAQFFLD NVPTQVKYLV LDYEDDPSGN AQANTNACLR FMQMIADAGY
TPIYYSYKPF TLDNVDYQQI LAQFPNSLWI AGYGLNDGNA DFEYFPSMDG IRWWQYSSNP
FDKNIVLLDD EEDEKPKTAG TWKQDSKGWW FRRNNGSFPY NKWEKIGGVW YYFDSKGYCL
TSEWLKDNEK WYYLKDNGAM VTGWVLVGSE WYYMDDSGAM VTGWVKYKNN WYYMTNERGN
MVSNEFIKSG KGWYFMNTNG ELADNPSFTK EPDGLITVA